Concepedia

Erik M. van Maarseveen

EM

32

Publications

1.2K

Citations

20

H-Index

2003

Active since

Affiliations

University Medical Center Utrecht(Current)

Utrecht University

The Netherlands Cancer Institute

Oncode Institute

Memorial Sloan Kettering Cancer Center

Erik M. van Maarseveen is an author at University Medical Center Utrecht specializing in medicine, pharmacology, and engineering.

ORCID

Top concepts

Publications per year

2003–2020

32

Publications

32

Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes

Jan Hein van Steenis, Erik M. van Maarseveen, F.J. Verbaan et al. · Journal of Controlled Release · 2003 · 118 citations

, , +3

Fludarabine and Exposure-Targeted Busulfan Compares Favorably with Busulfan/Cyclophosphamide-Based Regimens in Pediatric Hematopoietic Cell Transplantation: Maintaining Efficacy with Less Toxicity

Imke H. Bartelink, Elisabeth M L van Reij, Corinne Gerhardt et al. · Biology of Blood and Marrow Transplantation · 2013 · 105 citations · Full text

Impact of Medication Adherence on the Effect of Renal Denervation

Rosa L. de Jager, Esther de Beus, Martine M. A. Beeftink et al. · Hypertension · 2017 · 82 citations · Full text

Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes

Jurgen Langenhorst, Charlotte van Kesteren, Erik M. van Maarseveen et al. · Blood Advances · 2019 · 73 citations · Full text

Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

Jurgen Langenhorst, Thomas P. C. Dorlo, Erik M. van Maarseveen et al. · Clinical Pharmacokinetics · 2018 · 67 citations · Full text

Rows per page

1–5 of 32